chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: Very intense sneezing; Stuffy nose; Eyes watering; Runny nose allergy attack at midnight; Trouble sleeping all night; Arm soreness; This is a spontaneous report from a contactable other health care professional, the patient. A 33-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via unspecified route of administration in left arm, on 26Mar2021 at 13:15 (at the age of 33 years) as a single dose for COVID-19 immunisation. Medical history was not provided. The patient previously received codeine (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since having the vaccine. Concomitant medications included ambien (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), vyvanse (MANUFACTURER UNKNOWN), doxylamine (MANUFACTURER UNKNOWN) and armour thyroid (MANUFACTURER UNKNOWN) all for unknown indications from unknown dates and unknown if ongoing. On unknown date in Mar2021, the patient experienced arm soreness, very intense sneezing, stuffy nose, eyes watering, runny nose allergy attack at midnight and trouble sleeping all night. The patient received albuterol breathing treatment, ibuprofen, zyrtec, afrin treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events arm soreness, very intense sneezing, stuffy nose, eyes watering, runny nose allergy attack at midnight and trouble sleeping all night were not recovered at the time of report.    No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Product administered at inappropriate site
Clinical narrative: Vaccine administered at left leg; MILD BODY ACHES; FATIGUE; This is a spontaneous report received from a contactable consumer, the patient. A 54-years-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206 via an unspecified route of administration in left leg on 18Mar2021, 04:30 PM, (at the age of 54 years old) as a single dose for COVID-19 immunisation. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in right arm on 25Feb2021,16:30, (at the age of 54 years) as a single dose, for COVID-19 immunisation. Medical history of the patient included drug allergy (Allergies to NYSTATIN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Patient received antibiotics within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar 2021 the patient experienced mild body aches and fatigue. The vaccine was administered in left leg (Vaccine administered at inappropriate site). No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events body aches and fatigue was not recovered and vaccine administered at inappropriate site was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Retching
Clinical narrative: Rapidly increasing fever over about 30 minutes.; Acute bout of nausea; Dry heaving; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 03Mar2021 at 13:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation.  Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient woke up in the middle of the night at 01:30 (approximately 14 hours after the second dose) with a rapidly increasing fever over about 30 minutes, also experienced acute bout of nausea, followed by dry heaving for about ten minutes which happened again at 08:30. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event.  The clinical outcome of the events fever, nausea, vomiting and dry heaving was resolving at the time of this report.  No follow-up attempts are needed. No further information expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EP6955), via an unspecified route of administration in the left arm on 24Mar2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. The concomitant medications included vitamin d (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC), l-thyroxine (MANUFACTURER UNKNOWN) and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN) for an unknown indication. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 13:00 the patient experienced injection site soreness. The patient did not receive any treatment for reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vaccination site pain was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Influenza like illness, Pain, Pyrexia
Clinical narrative: similar to having flu; severe body aches; crushing joint pain; fever; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID- mRNA VACCINE, Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 09.15 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID- mRNA VACCINE, Lot number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 09.30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Patient was allergic to sulfa drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the Patient had not tested for COVID-19. On 24Mar2021 at 20.00 approximately 12 hours after the vaccination, the patient experienced severe body aches, crushing joint pain, fever, fatigue similar to having the flu, but so much worse than anything patient had experienced. It was agony. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the severe body aches, crushing joint pain, fever, fatigue and flu like symptoms was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Gait inability, Joint swelling
Clinical narrative: Severe swelling in right knee; unable to walk.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 19Mar2021 at 11:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history and allergies to medications or foods or other products were reported as no. Concomitant medications received within 2 weeks of vaccination included WELLBUTRIN, CRESTOR from an unknown date for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 00:00, the patient experienced severe swelling in right knee and unable to walk. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events severe swelling in right knee and unable to walk was resolving at the time of this report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Dizziness, Electric shock sensation
Clinical narrative: 103 fever; chills; cold sweats; Injection arm was so sore; shocks; dizzy; severe increase in heart rate; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 23Mar2021 at 10:15 (at the age of 27 years) as a single dose for COVID-19 immunisation. Medical history included ITP (idiopathic thrombocytopenia purpura). Concomitant medications reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, immediately following injection, the patient experienced severe increase in heart rate. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On same day at 22:00 within 12 hours after vaccine, the patient experienced a 103 fever with chills and cold sweats, injection arm was so sore that the patient could not move it at all without severe pain. When patient tried to sleep, she had shocks every 15 to 30 minutes throughout the body. The fever continued for 36 hours including the fever, chills, and shock. The patient was dizzy the entire time with trouble standing. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab test body temperature measurement on 23Mar2021 and the recording was 103 (unspecified units). The clinical outcome of the events increased heart rate, fever, chills, cold sweat, vaccination site pain, electric shock sensation and dizzy was resolving at the time of this report.   No follow-up attempts are possible. Information about lot/ batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pyrexia, Vaccination site pain
Clinical narrative: 103 fever; chills; cold sweats; Injection arm was so sore; shocks; dizzy; severe increase in heart rate; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 23Mar2021 at 10:15 (at the age of 27 years) as a single dose for COVID-19 immunisation. Medical history included ITP (idiopathic thrombocytopenia purpura). Concomitant medications reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, immediately following injection, the patient experienced severe increase in heart rate. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On same day at 22:00 within 12 hours after vaccine, the patient experienced a 103 fever with chills and cold sweats, injection arm was so sore that the patient could not move it at all without severe pain. When patient tried to sleep, she had shocks every 15 to 30 minutes throughout the body. The fever continued for 36 hours including the fever, chills, and shock. The patient was dizzy the entire time with trouble standing. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab test body temperature measurement on 23Mar2021 and the recording was 103 (unspecified units). The clinical outcome of the events increased heart rate, fever, chills, cold sweat, vaccination site pain, electric shock sensation and dizzy was resolving at the time of this report.   No follow-up attempts are possible. Information about lot/ batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: 101 Fever; This is a spontaneous report from a contactable consumer. A 25-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in left arm on 25Mar2021 at 08:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6205) via an unspecified route of administration in left arm on 04Mar2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 (evening of the second dose), the patient experienced 101 (unit unspecified) fever. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event fever was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: slight fever (99.3); Chills; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration in the left arm 24Mar2021 at 13:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was reported as no. The concomitant medications included ALEVE. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EJ1685) via an unspecified route of administration in the left arm 03Mar2021 at 10:00 (at the age of 61-years-old). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 13.00(24 hours following the 2nd shot) the patient experienced chilled and slight fever (99.3) for about 4 hours and head ache but again only for about 4 hours then she was fine. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills and headache was recovered on 25Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fever; Body aches; headache; injection site pain and swelling; injection site pain and swelling; Swollen lymph nodes just felt crappy.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:15 (at the age of 56-years old) as a single dose for COVID-19 immunisation. Medical history included diabetics. The patient had a history of allergy to antibiotics. The patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 24Mar2021 at 23:00, the patient had experienced fever, body aches, headache, injection site pain and swelling and swollen lymph nodes just felt crappy. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, body aches, headache, injection site pain and swelling and swollen lymph nodes just felt crappy was resolved on an unknown date in Mar2021.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Fever; Body aches; headache; injection site pain and swelling; injection site pain and swelling; Swollen lymph nodes just felt crappy.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 11:15 (at the age of 56-years old) as a single dose for COVID-19 immunisation. Medical history included diabetics. The patient had a history of allergy to antibiotics. The patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 24Mar2021 at 23:00, the patient had experienced fever, body aches, headache, injection site pain and swelling and swollen lymph nodes just felt crappy. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, body aches, headache, injection site pain and swelling and swollen lymph nodes just felt crappy was resolved on an unknown date in Mar2021.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Persistent headache; Body aches; Fatigue; This is a spontaneous report from a contactable company representative, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in left arm on 24Mar2021 at 14:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history provided as not applicable (reported as N/A). The patient had no known allergies to food, medications, or other products. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in left arm on 03Mar2021 at 14:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Concomitant medications received within two weeks of vaccination included ibuprofen (ADVIL), loratadine (MANUFACTURER UNKNOWN) 10 mg; pseudoephedrine HCl (MANUFACTURER UNKNOWN) 30 mg, for known indication and from unknown date. On 25Mar2021 at 03:00, the patient experienced persistent headache, body aches and fatigue. The patient did not receive any treatment for events persistent headache, body aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of persistent headache, body aches and fatigue were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Tenderness
Clinical narrative: lump near my left collar bone; tender to the touch; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247), via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247), via an unspecified route of administration in the left arm on 03Mar2021 at 09:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 06:00, the patient experienced lump near left collar bone and was tender to the touch. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the lump near left collar bone and tenderness was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chest pain, Chills, Headache
Clinical narrative: Very weak; carotid artery and a pain in right chest started coming and going; Fever; shivering pretty bad; Achy all over; Slight headache throughout the day; Couldn't sleep most all night; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in left arm on 24Mar2021 at 09:15 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient medical history included gallbladder taken out 3 years ago and penicillin allergy from birth. Concomitant medications included crestor (MANUFACTURER UNKNOWN) 20mg/daily started on an unknown date for unknown indication and hydrochlorothiazide (MANUFACTURER UNKNOWN) 25mg started on an unknown date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. It was reported that the patient was ok until about 7pm and started getting a fever (100.1), shivering pretty bad, achy all over, slight headache throughout the day (24Mar21). Tried to sleep but could not sleep most all night, shivery, fever, tossed and turned all night. Next day, felt pretty good, slight fever but not as bad but about noon, started feeling all the same symptoms again throughout the rest of the day 25Mar2021. The patient had another thing happen (believed was unrelated but). What she thought was her carotid artery and a pain in right chest started coming and going. Today (26MAR2021) so far, she felt just very weak (9:02am) so should go slow. The patient hope that she done with the bad symptoms. She took ADVIL but it still came and went. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab tests and procedures, which included fever with 100.1 (units unspecified). The clinical outcome of Achy all over, carotid artery and a pain in right chest started coming and going, couldn't sleep most all sight, fever, shivering pretty bad, slight headache and weakness throughout the day was resolved on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pyrexia
Clinical narrative: Very weak; carotid artery and a pain in right chest started coming and going; Fever; shivering pretty bad; Achy all over; Slight headache throughout the day; Couldn't sleep most all night; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in left arm on 24Mar2021 at 09:15 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient medical history included gallbladder taken out 3 years ago and penicillin allergy from birth. Concomitant medications included crestor (MANUFACTURER UNKNOWN) 20mg/daily started on an unknown date for unknown indication and hydrochlorothiazide (MANUFACTURER UNKNOWN) 25mg started on an unknown date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. It was reported that the patient was ok until about 7pm and started getting a fever (100.1), shivering pretty bad, achy all over, slight headache throughout the day (24Mar21). Tried to sleep but could not sleep most all night, shivery, fever, tossed and turned all night. Next day, felt pretty good, slight fever but not as bad but about noon, started feeling all the same symptoms again throughout the rest of the day 25Mar2021. The patient had another thing happen (believed was unrelated but). What she thought was her carotid artery and a pain in right chest started coming and going. Today (26MAR2021) so far, she felt just very weak (9:02am) so should go slow. The patient hope that she done with the bad symptoms. She took ADVIL but it still came and went. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab tests and procedures, which included fever with 100.1 (units unspecified). The clinical outcome of Achy all over, carotid artery and a pain in right chest started coming and going, couldn't sleep most all sight, fever, shivering pretty bad, slight headache and weakness throughout the day was resolved on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Headache, Night sweats
Clinical narrative: headache; sensitive skin (itchy); welted when scratched; fuzzy brain; light headed; Tired; night sweats; body ache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: eR2613) via an unspecified route administration on 23Mar2021 at 13:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN LOW); all from unknown dates for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 00:00, for around 65 hours, the patient experienced body ache, headache, sensitive skin (itchy), welted when scratched, fuzzy brain, light headed, tiredness and night sweats. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, headache, itchy skin, welts, fuzzy brain, light headed, tiredness and night sweats was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Urticaria
Clinical narrative: headache; sensitive skin (itchy); welted when scratched; fuzzy brain; light headed; Tired; night sweats; body ache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: eR2613) via an unspecified route administration on 23Mar2021 at 13:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN LOW); all from unknown dates for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 00:00, for around 65 hours, the patient experienced body ache, headache, sensitive skin (itchy), welted when scratched, fuzzy brain, light headed, tiredness and night sweats. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, headache, itchy skin, welts, fuzzy brain, light headed, tiredness and night sweats was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chapped lips, Dry mouth, Hair colour changes, Hair growth abnormal, Lip dry
Clinical narrative: Swelling of the lips (inside mouth); Swelling of cheeks (inside mouth); Dry mouth (inside mouth and forward to lips); Cracked lips; Extremely dry lips; Abnormal hair growth around mouth; Emergence of black hair in beard when previously white; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route administration in the left arm on 02Mar2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Relevant medical history included high blood pressure and obese (obesity). Concomitant medication was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021, the patient experienced swelling of the lips and cheeks (inside mouth), dry mouth (inside mouth and forward to lips), cracked and extremely dry lips and abnormal hair growth around mouth (new hair along lip line and emergence of black hair in beard when previously white). No treatment was received for the events experienced. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events swelling of the lips, swelling of cheeks, dry mouth, cracked lips, extremely dry lips, abnormal hair growth around mouth and emergence of black hair in beard were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: Swelling of the lips (inside mouth); Swelling of cheeks (inside mouth); Dry mouth (inside mouth and forward to lips); Cracked lips; Extremely dry lips; Abnormal hair growth around mouth; Emergence of black hair in beard when previously white; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route administration in the left arm on 02Mar2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Relevant medical history included high blood pressure and obese (obesity). Concomitant medication was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021, the patient experienced swelling of the lips and cheeks (inside mouth), dry mouth (inside mouth and forward to lips), cracked and extremely dry lips and abnormal hair growth around mouth (new hair along lip line and emergence of black hair in beard when previously white). No treatment was received for the events experienced. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events swelling of the lips, swelling of cheeks, dry mouth, cracked lips, extremely dry lips, abnormal hair growth around mouth and emergence of black hair in beard were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Soreness in left arm; Chills overnight; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 32-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 as single dose (at the age of 32-years-old) for COVID-19 immunisation. The medical history of the patient was reported as none. Concomitant medication included doxycycline (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 12:00, the patient experienced soreness in left arm, chills overnight, fatigue, muscle aches, headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in arm, chills, fatigue, muscle aches, headache were resolving.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; feeling of light headedness; This is a spontaneous report from a contactable consumer, the patient. A 73-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 18Mar2021 at 12:00 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patients medical history was not reported. Concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on 22Feb2021 at 12:00 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. It was unknown if the patient was allergic to medications, food or other products. It was unknown whether the patient had received any other vaccines 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced dizziness and feeling of light headedness at times more than a week after second shot of vaccine. No treatment was taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizziness and feeling of light headedness was not recovered at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain in extremity, Vaccination site mass
Clinical narrative: arm still hurts.; has nerve pain shooting down it into my hand.; hard large lump at the site of injection.; This is a spontaneous report from a contactable nurse, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an intramuscular route of administration in the left arm on 26Feb2021 at 14:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included mast cell activation (MCAS), Ehlers-Danlos syndrome (EDS), postural orthostatic tachycardia syndrome (POTS). The patient was allergic to pineapple. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included metoclopramide (MANUFACTURER UNKNOWN), cyclobenzaprine (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN), propranolol (MANUFACTURER UNKNOWN) and duloxetine hydrochloride (CYMBALTA); all taken for unknown indications from an unknown date. On 26Feb2021 at 16:00, the patient arm still hurts, had nerve pain shooting down it into the hand and a hard large lump at the site of injection. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events pain in arm, nerve pain and vaccination site lump were not resolved at the time of the report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash maculo-papular
Clinical narrative: rash on my stomach, back, and thighs, was large and splotchy, red, and slightly raised; red rash; It was not itchy, but tender in rash areas; This is a spontaneous report from a contactable consumer, the patient. A 44-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in thr left arm on 20Mar2021 at 18:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was allergic to possibly raw tuna (like sushi). The patient had not received any other vaccines within four weeks prior to the vaccine. The patient did not receive other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 00:00, the patient developed a rash on her stomach, back, and thighs. It was large and splotchy, red, and slightly raised. It was not itchy, but tender in those areas. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did a telehealth visit with her doctor. and the doctor thought it was a histamine response and not an allergic reaction. But the patient had not seen this type of rash listed anywhere. Only a rash at injection site was listed. The patient did not receive any treatment for the reported events. On nights 2 and 3 after vaccination, the patient had rash on her stomach, back, and thighs, it was large and splotchy, red, and slightly raised and tender in those areas. The clinical outcome of the events rash on her stomach, back, and thighs, it was large and splotchy, red, and slightly raised and tender in those areas were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Body aches; Low fever; chills; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in right arm on 25Mar2021 at 12:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and high cholesterol. The patient was allergic to contrast IV dye and erythromycin. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), and cod liver oil (MANUFACTURER UNKNOWN) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in right arm on 03Mar2021 at 17:00 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 (also reported as at 02:00), the patient experienced low fever, body aches and chills. Therapeutic measure was taken as result of events included treatment with TYLENOL (self-administered). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events low fever, body aches and chills were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Hypokinesia
Clinical narrative: Flu-like symptons; 101 Fever; Chills; body ache; fatigue; headache; Arm injection site extremely sore; Arm injection site extremely sore, to the point of arm immobility; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6204) via an unspecified route of administration in the right arm on 20Mar2021 at 13:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the right arm on 27Feb201 at 18:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient did not have any allergies to food, medications, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. On 20Mar2021, after 5 hours of second shot, patient experienced arm injection site extremely sore, to the point of arm immobility. On 21Mar2021, the patient experienced flu-like symptoms the day after second shot, 101 fever, chills, body aches, fatigue, headache. The patient underwent lab tests and procedures which included body temperature and result was 101 fever (units not specified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment was not received as a result of reported events. The clinical outcome of flu-like symptoms, fever, chills, general body pain, fatigue, headache, vaccination site pain and movement reduced (arm immobility) were resolved on an unknown date of Mar2021, at the time of this report. No follow-up attempts are possible. No further information is expected.